Top Stories
SEBI proposes key change in commodity derivatives; seeks public comments Marico Q4: India volume growth at 9% in line; guides high single-digit volumes for FY27 Marico Q4 FY26 Results: Revenue up 22%, profit grows 14% despite margin contraction PNB Q4 Results: Profit jumps 14%, GNPA improves, but NII slips Caplin Point subsidiary receives USFDA approval for Calcium Gluconate Injection; targets $71 million US market LTM, Uniphore join hands to build industry-specific AI solutions for enterprises Lupin secures USFDA approval for rare disease drug with $337 million opportunity IndiGo turmoil deepens: Another top executive quits after CEO exit SEBI proposes key change in commodity derivatives; seeks public comments Marico Q4: India volume growth at 9% in line; guides high single-digit volumes for FY27 Marico Q4 FY26 Results: Revenue up 22%, profit grows 14% despite margin contraction PNB Q4 Results: Profit jumps 14%, GNPA improves, but NII slips Caplin Point subsidiary receives USFDA approval for Calcium Gluconate Injection; targets $71 million US market LTM, Uniphore join hands to build industry-specific AI solutions for enterprises Lupin secures USFDA approval for rare disease drug with $337 million opportunity IndiGo turmoil deepens: Another top executive quits after CEO exit
TAG

# Shri Lal Singh